Infusyn Therapeutics

Infusyn Therapeutics' Precision Dosing System (PDS) has already helped thousands of patients treat pain and spasms and is currently developing a breakthrough drug for pulmonary arterial hypertension (PAH), which is expected to significantly improve the lives of approximately 50,000 PAH patients.